137 related articles for article (PubMed ID: 35998229)
1. CXCR3 isoform A promotes head and neck cancer progression by enhancing stem-like property and chemoresistance.
Sun WH; Peng TJ; Tang SJ; Lin JY; Wang CY; Fang HJ; Sun KH
J Oral Pathol Med; 2022 Oct; 51(9):791-800. PubMed ID: 35998229
[TBL] [Abstract][Full Text] [Related]
2. Disparate roles of CXCR3A and CXCR3B in regulating progressive properties of colorectal cancer cells.
Li H; Rong S; Chen C; Fan Y; Chen T; Wang Y; Chen D; Yang C; Yang J
Mol Carcinog; 2019 Feb; 58(2):171-184. PubMed ID: 30302818
[TBL] [Abstract][Full Text] [Related]
3. CXCR3A contributes to the invasion and metastasis of gastric cancer cells.
Yang C; Zheng W; Du W
Oncol Rep; 2016 Sep; 36(3):1686-92. PubMed ID: 27461521
[TBL] [Abstract][Full Text] [Related]
4. Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion.
Wu Q; Dhir R; Wells A
Mol Cancer; 2012 Jan; 11():3. PubMed ID: 22236567
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy with 5-aminolevulinic acid (ALA) impairs tumor initiating and chemo-resistance property in head and neck cancer-derived cancer stem cells.
Yu CH; Yu CC
PLoS One; 2014; 9(1):e87129. PubMed ID: 24475244
[TBL] [Abstract][Full Text] [Related]
6. The Chemokine Receptor CXCR3 Isoform B Drives Breast Cancer Stem Cells.
Kundu N; Ma X; Brox R; Fan X; Kochel T; Reader J; Tschammer N; Fulton A
Breast Cancer (Auckl); 2019; 13():1178223419873628. PubMed ID: 31619923
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.
Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
[TBL] [Abstract][Full Text] [Related]
8. The CXCL11-CXCR3A axis influences the infiltration of CD274 and IDO1 in oral squamous cell carcinoma.
Wang X; Zhang J; Zhou G
J Oral Pathol Med; 2021 Apr; 50(4):362-370. PubMed ID: 33187013
[TBL] [Abstract][Full Text] [Related]
9. PDK1- and PDK2-mediated metabolic reprogramming contributes to the TGFβ1-promoted stem-like properties in head and neck cancer.
Sun WH; Chen YH; Lee HH; Tang YW; Sun KH
Cancer Metab; 2022 Dec; 10(1):23. PubMed ID: 36474273
[TBL] [Abstract][Full Text] [Related]
10. Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas.
Chang YC; Jan CI; Peng CY; Lai YC; Hu FW; Yu CC
Oncotarget; 2015 Sep; 6(27):24002-16. PubMed ID: 26090866
[TBL] [Abstract][Full Text] [Related]
11. C-X-C motif receptor 3A enhances proliferation and invasiveness of colorectal cancer cells, and is mediated by C-X-C motif ligand 10.
Nozaki E; Kobayashi T; Ohnishi H; Ohtsuka K; Masaki T; Watanabe T; Sugiyama M
Oncol Lett; 2020 Mar; 19(3):2495-2501. PubMed ID: 32194750
[TBL] [Abstract][Full Text] [Related]
12. Potential role of CXCR3 in proliferation and invasion of prostate cancer cells.
Shen D; Cao X
Int J Clin Exp Pathol; 2015; 8(7):8091-8. PubMed ID: 26339376
[TBL] [Abstract][Full Text] [Related]
13. Functional Analysis of CXCR3 Splicing Variants and Their Ligands Using NanoBiT-Based Molecular Interaction Assays.
Nguyen HT; Hurh S; Nguyen LP; Nguyen TU; Park HK; Seong JY; Lee CS; Ham BJ; Hwang JI
Mol Cells; 2023 May; 46(5):281-297. PubMed ID: 36799104
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation.
Yu CC; Chen YW; Chiou GY; Tsai LL; Huang PI; Chang CY; Tseng LM; Chiou SH; Yen SH; Chou MY; Chu PY; Lo WL
Oral Oncol; 2011 Mar; 47(3):202-10. PubMed ID: 21292542
[TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha2b restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by modulating CXC receptor ligand interaction.
Chakraborty K; Bose A; Pal S; Chattopadhyay U; Baral R
J Interferon Cytokine Res; 2008 Aug; 28(8):487-99. PubMed ID: 18729739
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL
Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238
[TBL] [Abstract][Full Text] [Related]
17. Divergent roles of CXCR3 isoforms in promoting cancer stem-like cell survival and metastasis.
Li Y; Reader JC; Ma X; Kundu N; Kochel T; Fulton AM
Breast Cancer Res Treat; 2015 Jan; 149(2):403-15. PubMed ID: 25537642
[TBL] [Abstract][Full Text] [Related]
18. Differential expression profile of CXCR3 splicing variants is associated with thyroid neoplasia. Potential role in papillary thyroid carcinoma oncogenesis?
Urra S; Fischer MC; Martínez JR; Véliz L; Orellana P; Solar A; Bohmwald K; Kalergis A; Riedel C; Corvalán AH; Roa JC; Fuentealba R; Cáceres CJ; López-Lastra M; León A; Droppelmann N; González HE
Oncotarget; 2018 Jan; 9(2):2445-2467. PubMed ID: 29416784
[TBL] [Abstract][Full Text] [Related]
19. Differential expression patterns of CXCR3 variants and corresponding CXC chemokines in clear cell ovarian cancers and endometriosis.
Furuya M; Yoneyama T; Miyagi E; Tanaka R; Nagahama K; Miyagi Y; Nagashima Y; Hirahara F; Inayama Y; Aoki I
Gynecol Oncol; 2011 Sep; 122(3):648-55. PubMed ID: 21684584
[TBL] [Abstract][Full Text] [Related]
20. Neem leaf glycoprotein restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by maintaining CXCR3/CXCL10 balance.
Chakraborty K; Bose A; Pal S; Sarkar K; Goswami S; Ghosh D; Laskar S; Chattopadhyay U; Baral R
Int Immunopharmacol; 2008 Feb; 8(2):330-40. PubMed ID: 18182249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
